Cholesterol-lowering effects of dietary fiber: A meta-analysis

American Journal of Clinical Nutrition

Volumn 69, Issue 1, 1999, Pages 30-42

  Brown, Lisa ^a   Rosner, Bernard ^b   Willett, Walter W ^b   Sacks, Frank M ^b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b NONE

Author keywords

Controlled trials; Dose response; Fiber; HDL cholesterol; High density lipoprotein cholesterol; Humans; LDL cholesterol; Low density lipoprotein cholesterol; Meta analysis; Total cholesterol; Triacylglycerols

Indexed keywords

CHOLESTEROL; GUAR GUM; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ISPAGULA; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PECTIN;

ARTICLE; BRAN; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; DIETARY FIBER; DIETARY INTAKE; DOSE RESPONSE; HUMAN; META ANALYSIS; OAT;

AVENA; CYAMOPSIS TETRAGONOLOBA; PLANTAGO OVATA;

EID: 0032944280     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/69.1.30     Document Type: Article

References (110)

1. National Center for Health Statistics and the American Heart Association. Facts about cardiovascular disease. Circulation 1992;85: A103 (abstr).
2. Kannel WB, Castelli WD, Gordon T, McNamara PM. Serum cholesterol, lipoproteins, and risk of coronary artery disease. The Framingham Study. Ann Intern Med 1971;74:1-12.
3. Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 1996;335:1001-9.
4. Byington RP, Jukema JW, Salonen JT. et al. Reduction in cardiovascular events during pravastatin therapy: pooled analysis of clinical events of the Pravastatin Atherosclerosis Intervention Program. Circulation 1995;92:2419-25.
5. Kushi LH, Lew RA, Stare FJ, et al. Diet and 20-year mortality from coronary heart disease: the Ireland-Boston Diet-Heart Study. N Engl J Med 1985;312:811-8.
6. Burr ML, Fehily AM, Gilbert JF. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction. Lancet 1989;2: 757-61.
7. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA 1993;269:3015-23.
8. Trowell HC, Burkitt DP, eds. Western diseases: their emergence and prevention. Cambridge, MA: Harvard University Press. 1981.
9. Eastwood MA, Passmore R. Dietary fibre. Lancet 1983;2:202-6.
10. Truswell AS. Dietary fibre and plasma lipids. Eur J Clin Nutr 1995;49(suppl):S105-9.
11. Glore SR, Van Treeck D, Knehans AW, Guild M. Soluble fiber and serum lipids: a literature review. J Am Diet Assoc 1994;94:425-36.
12. Kris-Etherton PM, Krummel D, Russell ME, et al. The effect of diet on plasma lipids, lipoproteins, and coronary heart disease. J Am Diet Assoc 1988;88:1373-400.
13. Bell LP, Hectorn KJ, Reynolds H, Hunninghake DB. Cholesterol-lowering effects of soluble-fiber cereals as part of a prudent diet for patients with mild to moderate hypercholesterolemia. Am J Clin Nutr 1990;52:1020-6.
14. Anderson JW. Dietary fibre, complex carbohydrate, and coronary artery disease. Can J Cardiol 1995;11(suppl G):55G-62G.
15. Ripsin CM, Keenan JM, Jacobs DR, et al. Oat products and lipid lowering: a meta-analysis. JAMA 1992;267:3317-25.
16. Keys, Anderson JT, Grande F. Prediction of serum cholesterol responses of man to changes in fats in the diet. Lancet 1957;2:959-66.
17. Brussaard JH, Katan MB, Groot PHE, Havekes LM, Hautvast JGAJ. Serum lipoproteins of healthy persons fed a low-fat diet or a polyunsaturated fat diet for three months. A comparison of two cholesterol-lowering diets. Atherosclerosis 1982;42:205-19.
18. Keys A, Anderson JT, Grande F. Serum cholesterol response to changes in the diet, I-IV. Metabolism 1965;14:747-87.
19. US Department of Agriculture. USDA handbook 8 series: composition of foods. Washington, DC: US Department of Agriculture, 1976-1992. (Agriculture handbooks no. 8-1-8-21.)
20. Nutrition Coordinating Center. Minnesota nutrient data system (NDS) software. Minneapolis: University of Minnesota.
21. Anderson JW. Plant fiber in foods. 2nd ed. Lexington, KY: HCF Nutrition Research Foundation Inc. 1990.
22. D'Agostino RB, Weintraub M. Meta-analysis: a method for synthesizing research. Clin Pharmacol Ther 1995;58:605-16.
23. US Department of Health and Human Services, Public Health Service. The Lipid Research Clinics population studies data book. Vol 1. The prevalence study. Bethesda, MD: National Institutes of Health. 1980. (NIH publication no. 80-1527.)
24. Jacobs DR, Barrett-Connor EB. Retest reliability of plasma cholesterol and triglyceride. Am J Epidemiol 1982;116:878-85.
25. Rosner B, Polk BF. Predictive values of routine blood pressure measurements in screening for hypertension. Am J Epidemiol 1983;117:429-42.
26. Davis CE, Rifkind BM, Brenner H, Gordon DJ. A single cholesterol measurement underestimates the risk of coronary heart disease. An empirical example from the Lipid Research Clinics Mortality Follow Up Study. JAMA 1990;264:3044-6.
27. Cook NR, Rosner BA. Sample size estimation for clinical trials with longitudinal measures: applications to studies of blood pressure. J Epidemiol Biostat 1997;2:65-74.
28. Friedlander Y, Kark JD, Stein Y. Variability of plasma lipids and lipoproteins: the Jerusalem Lipid Research Clinic Study. Clin Chem 1985; 31:1121-6.
29. Laird N. Mosteller F. Some statistical methods for combining experimental results. Int J Technol Assess Health Care 1990;6: 5-30.
30. Kestin M, Moss R, Clifton PM, Nestel PJ. Comparative effects of three cereal brans on plasma lipids, blood pressure, and glucose metabolism in mildly hypercholesterolemic men. Am J Clin Nutr 1990;52:661-6.
31. Van Horn LV, Liu K, Parker D, et al. Serum lipid response to oat product intake with a fat-modified diet. J Am Diet Assoc 1986;86:759-64.
32. Leadbetter J, Ball MJ, Mann JI. Effects of increasing quantities of oat bran in hypercholesterolemic people. Am J Clin Nutr 1991;54:841-5.
33. Davidson MH, Dugan LD, Burns JH, Bova J, Story K, Drennan KB. The hypocholesterolemic effects of β-glucan in oatmeal and oat bran: a dose-controlled study. JAMA 1991;265:1833-9.
34. SAS Institute Inc. SAS/STAT user's guide, version 6, 4th ed. Vol 2. Cary, NC: SAS Institute Inc, 1989.
35. Mensink RP, Katan MB. Effect of dietary fatty acids on serum lipids and lipoproteins: a meta-analysis of 27 trials. Arterioscler Thromb 1992;12:911-9.
36. Mackay S, Ball MJ. Do beans and oat bran add to the effectiveness of a low-fat diet? Eur J Clin Nutr 1992;46:641-8.
37. Fagerberg S-E. The effects of a bulk laxative (Metamucil®) on fasting blood glucose, serum lipids, and other variables in constipated patients with non-insulin dependent adult diabetes. Curr Ther Res 1982;31:166-72.
38. Judd PA, Truswell AS. Comparison of the effects of high-and low-methoxyl pectins on blood and faecal lipids in man. Br J Nutr 1982;48:451-8.
39. Anderson JW, Gilinsky NH, Deakins DA, et al. Lipid responses of hypercholesterolemic men to oat-bran and wheat-bran intake. Am J Clin Nutr 1991;54:678-83.
40. Anderson JW, Spencer DB, Hamilton CC, et al. Oat-bran cereal lowers serum total and LDL cholesterol in hypercholesterolemic men. Am J Clin Nutr 1990;52:495-9.
41. Bremer JM, Scott RS, Lintott CJ. Oat bran and cholesterol reduction: evidence against specific effect. Aust NZJ Med 1991;21: 422-6.
42. Demark-Wahnefried W. Bowering J. Cohen PS. Reduced serum cholesterol with dietary change using fat-modified and oat bran supplemented diets. J Am Diet Assoc 1990;90:223-9.
43. Gold KV, Davidson DM. Oat bran as a cholesterol-reducing dietary adjunct in a young, healthy population. West J Med 1988; 148:299-302.
44. Gormley TR, Kevany J. O'Donnell B, McFarlane R. Investigation of the potential of porridge as a hypocholesterolaemic agent. Int J Food Sci Technol 1978;2:85-91.
45. Kashtan H, Stern HS, Jenkins DJA, et al. Wheat-bran and oat-bran supplements' effects on blood lipids and lipoproteins. Am J Clin Nutr 1992;55:976-80.
46. Keenan JM, Wenz JB, Myers S, Ripsin C, Huang Z. Randomized, controlled, crossover trial of oat bran in hypercholesterolemic subjects. J Fam Pract 1991;33:600-8.
47. Lepre F, Crane S. Effect of oatbran on mild hyperlipidaemia. Med J Aust 1992;157:305-8.
48. O'Brien LT, Barnard RJ, Hall JA, Pritikin N. Effects of a high-complex-carbohydrate low-cholesterol diet plus bran supplement on serum lipids. J Appl Nutr 1985;37:26-34.
49. Poulter N, Chang CL, Cuff A, Poulter C, Sever P, Thorn S, Lipid profiles after the daily consumption of an oat-based cereal: a controlled crossover trial. Am J Clin Nutr 1994;59:66-9.
50. Stewart FM, Neutze JM, Newsome-White R. The addition of oatbran to a low fat diet has no effect on lipid values in hypercholesterolaemic subjects. N Z Med J 1992;105:398-400.
51. Swain JF, Rouse IL, Curley CB, Sacks FM. Comparison of the effects of oat bran and low-fiber wheat on serum lipoprotein levels and blood pressure. N Engl J Med 1990;322:147-52.
52. Törrönen R, Kansanen L, Uusitupa M, et al. Effects of an oat bran concentrate on serum lipids in free-living men with mild to moderate hypercholesterolemia. Eur J Clin Nutr 1992;46:621-7.
53. Turnbull WH, Leeds AR. The effect of rolled oats and a reduced/modified fat diet on apolipoprotein AI and B. J Clin Nutr Gastroenterol 1989;1:15-9.
54. Turnbull WH, Leeds AR. Reduction of total and LDL-cholesterol in plasma by rolled oats. J Clin Nutr Gastroenterol 1987;2:177-81.
55. Uusitupa MIJ, Ruuskanen E, Mäkinen E, et al. A controlled study on the effect of beta-glucan-rich oat bran on serum lipids in hypercholesterolemic subjects: relation to apolipoprotein E phenotype. J Am Coll Nutr 1992;11:651-9.
56. Van Horn L, Moag-Stahlberg A, Liu K, et al. Effects on serum lipids of adding instant oats to usual American diets. Am J Public Health 1991;81:183-8.
57. Van Horn L, Emidy LA, Liu K, et al. Serum lipid response to a fat-modified, oatmeal-enhanced diet. Prev Med 1988;17:377-86.
58. Whyte JL, McArthur R, Topping D, Nestel P. Oat bran lowers plasma cholesterol levels in mildly hypercholesterolemic men. J Am Diet Assoc 1992;92:446-9.
59. Zhang JX, Hallmans G, Andersson H, et al. Effect of oat bran on plasma cholesterol and bile acid excretion in nine subjects with ileostomies. Am J Clin Nutr 1992:56:99-105.
60. Anderson JW, Zettwoch N, Feldman T, Tietyen-Clark J, Oeltgen P, Bishop CW. Cholesterol-lowering effects of psyllium hydrophilic mucilloid for hypercholesterolemic men. Arch Intern Med 1988;148:292-6.
61. Anderson JW, Floore TL, Geil PB, O'Neal DS, Balm TK. Hypocholesterolemic effects of different bulk-forming hydrophilic fibers as adjuncts to dietary therapy in mild to moderate hypercholesterolemia. Arch Intern Med 1991;151:1597-602.
62. Anderson JW, Riddell-Mason S, Gustafson NJ, Smith SF, Mackey M. Cholesterol-lowering effects of psyllium-enriched cereal as an adjunct to a prudent diet in the treatment of mild to moderate hypercholesterolemia. Am J Clin Nutr 1992;56:93-8.
63. Bell LP, Hectorne K, Reynolds H, Balm TK, Hunninghake DB. Cholesterol-lowering effects of psyllium hydrophilic mucilloid: adjunct therapy to a prudent diet for patients with mild to moderate hypercholesterolemia. JAMA 1989;261:3419-23.
64. Everson GT, Daggy BP, McKinley C, Story JA. Effects of psyllium hydrophilic mucilloid on LDL-cholesterol and bile acid synthesis in hypercholesterolemic men. J Lipid Res 1992;33:1183-92.
65. Levin EG, Miller VT, Muesing RA, Stoy DB, Balm TK, LaRosa JC. Comparison of psyllium hydrophilic mucilloid and cellulose as adjuncts to a prudent diet in the treatment of mild to moderate hypercholesterolemia. Arch Intern Med 1990;150:1822-7.
66. Maciejko JJ, Brazg R, Shah A, Patil S, Rubenfire M. Psyllium for the reduction of cholestyramine-associated gastrointestinal symptoms in the treatment of primary hypercholesterolemia. Arch Fam Med 1994;3:955-60.
67. Neal GW, Balm TK. Synergistic effects of psyllium in the dietary treatment of hypercholesterolemia. South Med J 1990;83:1131-7.
68. Roberts DCK, Truswell SA, Bencke A, Dewar HM, Farmakalidis E. The cholesterol-lowering effect of a breakfast cereal containing psyllium fibre. Med J Aust 1994;161:660-4.
69. Spence JD, Huff MW, Heidenheim P, et al. Combination therapy with colestipol and psyllium mucilloid in patients with hyperlipidemia. Ann Intern Med 1995;123:493-9.
70. Sprecher DL, Harris BV, Goldberg AC, et al. Efficacy of psyllium in reducing serum cholesterol levels in hypercholesterolemic patients on high-or low-fat diets. Ann Intern Med 1993; 119:545-54.
71. Stoy DB, LaRosa JC, Brewer BK. Mackey M, Meusing RA, Cholesterol-lowering effects of ready-to-eat cereal containing psyllium. J Am Diet Assoc 1993;93:910-2.
72. Summerbell CD, Manley P, Barnes D, Leeds A. The effects of psyllium on blood lipids in hypercholesterolaemic subjects. J Hum Nutr Diet 1994;7:147-51.
73. Wolever TMS, Jenkins DJA, Mueller S, et al. Psyllium reduces blood lipids in men and women with hyperlipidemia. Am J Med Sci 1994;307:269-73.
74. Wolever TMS, Jenkins DJA, Mueller S, et al. Method of administration influences the serum cholesterol-lowering effect of psyllium. Am J Clin Nutr 1994;59:1055-9.
75. Cerda JJ, Robbins FL. Burgin CW, Baumgartner TG, Rice RW. The effects of grapefruit pectin on patients at risk for coronary heart disease without altering diet or lifestyle. Clin Cardiol 1988;11: 589-94.
76. Hillman LC, Peters SG, Fisher CA, Pomare EW. The effects of the fiber components pectin, cellulose and lignin on serum cholesterol levels. Am J Clin Nutr 1985;42:207-13.
77. Mahalko JR, Sandstead HH, Johnson LK, et al. Effect of consuming fiber from corn bran, soy hulls, or apple powder on glucose tolerance and plasma lipids in type II diabetes. Am J Clin Nutr 1984;39:25-34.
78. Singh RB, Rastogi SS, Singh R, Ghosh S, Niaz MA. Effects of guava intake on serum total and high-density lipoprotein cholesterol levels and on systemic blood pressure. Am J Cardiol 1992; 70:1287-91.
79. Stasse-Wolthuis M, Albers HFF, van Jeveren JGC, et al. Influence of dietary fiber from vegetables and fruits, bran or citrus pectin on serum lipids, fecal lipids, and colonic function. Am J Clin Nutr 1980;33:1745-56.
80. Tinker LF, Schneeman BO, Davis PA, Gallaher DD, Waggoner CR. Consumption of prunes as a source of dietary fiber in men with mild hypercholesterolemia. Am J Clin Nutr 1991;53:1259-65.
81. Aro A, Uusitupa M, Voutilainen E, Hersio K, Korhonen T, Siitonen O. Improved diabetic control and hypocholesterolaemic effect induced by long-term dietary supplementation with guar gum in type 2 (insulin-dependent) diabetes. Diabetologia 1981;21:29-33.
82. Aro A, Uusitupa M, Voutilainen E, Korhonen T. Effects of guar gum in male subjects with hypercholesterolemia. Am J Clin Nutr 1984;39:911-6.
83. Chuang L, Jou T, Yang W, et al. Therapeutic effect of guar gum in patients with non-insulin-dependent diabetes mellitus. J Formos Med Assoc 1992;91:15-9.
84. Fuessl HS, Williams G, Adrian TE, Bloom SR. Guar sprinkled on food: effect on glycaemic control, plasma lipids and gut hormones in non-insulin dependent diabetic patients. Diabet Med 1987;4:463-8.
85. Holman RR, Steemson J, Darling P, Turner RC. No glycemic benefit from guar administration in NIDDM. Diabetes Care 1987;10: 68-71.
86. Khan AR, Khan GY, Mitchel A, Qadeer MA. Effect of guar gum on blood lipids. Am J Clin Nutr 1981;34:2446-9.
87. Lalor BC, Bhantnagar D, Winocour PH, et al. Placebo-controlled trial of the effects of guar gum and metformin on fasting blood glucose and serum lipids in obese, type 2 diabetic patients. Diabet Med 1990;7:242-5.
88. Landin K, Holm G, Tengborn L, Smith U. Guar gum improves insulin sensitivity, blood lipids, blood pressure, and fibrinolysis in healthy men. Am J Clin Nutr 1992;56:1061-5.
89. McIvor ME, Cummings CC, Van Duyn MA, et al. Long-term effects of guar gum on blood lipids. Atherosclerosis 1986;60:7-13.
90. Niemi MK, Keinanen-Kiukaanniemi SM, Salmela PI. Long-term effects of guar gum and microcrystalline cellulose on glycaemic control and serum lipids in type 2 diabetes. Eur J Clin Pharmacol 1988;34:427-9.
91. Requejo F. Uttenthal LO, Bloom SR. Effects of α-glucosidase inhibition and viscous fibre on diabetic control and postprandial gut hormone responses. Diabet Med 1990:7:515-20.
92. Superko HR, Haskell WL, Sawrey-Kubicek L, Farquhar JW. Effects of solid and liquid guar gum on plasma cholesterol and triglyceride concentrations in moderate hypercholesterolemia. Am J Cardiol 1988;62:51-5.
93. Tuomilehto J, Silvasti M, Manninen V, Uusitupa M, Aro A. Guar gum and gemfibrozil - an effective combination in the treatment of hypercholesterolemia. Atherosclerosis 1989;76:71-7.
94. Turner PR, Tuomilehto J, Happonen P, La Ville AE, Shaikh M, Lewis B. Metabolic studies on the hypolipidaemic effect of guar gum. Atherosclerosis 1990;81:145-50.
95. Uusitupa M, Tuomilehto J, Karttunen P, Wolf E. Long term effects of guar gum on metabolic control, serum cholesterol and blood pressure levels in type 2 (non-insulin-dependent) diabetic patients with high blood pressure. Ann Clin Res 1984;16(suppl):126-31.
96. Uusitupa M, Siitonen O, Savolainen K, Silvasti M, Penttila I. Parviainen M. Metabolic and nutritional effects of long-term use of guar gum in the treatment of noninsulin-dependent diabetes of poor metabolic control. Am J Clin Nutr 1989;49:345-51.
97. Vaaler S, Hanssen KF, Dahl-Jørgensen K, et al. Diabetic control is improved by guar gum and wheat bran supplementation. Diabet Med 1986;3:230-3.
98. Vuorinen-Markkola H, Sinisalo M, Koivisto VA. Guar gum in insulin-dependent diabetes: effects on glycemic control and serum lipoproteins. Am J Clin Nutr 1992;56:1056-60.
99. Anderson JW, Tietyen-Clark JT. Dietary fiber: hyperlipidemia, hypertension and coronary artery disease. Am J Gastroenterol 1986;81:907-19.
100. Federation of American Societies for Experimental Biology. Physiological effects and health consequences of dietary fiber. Washington, DC: US Department of Health and Human Services, 1987.
101. Nishina PM, Freedland RA. The effects of dietary fiber feeding on cholesterol metabolism in rats. J Nutr 1990;120:800-5.
102. Schneeman BO, Gallaher D. Effects of dietary fiber on digestive enzyme activity and bile acids in the small intestine. Proc Soc Exp Biol Med 1985;180:409-14.
103. Schneeman BO. Dietary fiber and gastrointestinal function. Nutr Rev 1987;45:129-32.
104. Blundell JE, Burley VJ. Satiation, satiety, and the action of fibre on food intake. Int J Obes 1987;11(suppl):9-25.
105. Kromhout D, Bosschieter EB, de Lezenne Coulander C. Dietary fiber and 10-year mortality from coronary heart disease, cancer and all causes: the Zutphen Study. Lancet 1982;2:518-21.
106. Morris JN, Marr JW, Clayton DG. Diet and heart: a postscript. Br Med J 1977;2:1307-14.
107. Khaw KT, Barrett-Connor E. Dietary fiber and reduced ischemic heart disease mortality rates in men and women: a 12-year prospective study. Am J Epidemiol 1987;126:1093-102.
108. Humble CG, Malarcher AM, Tyroler HA. Dietary fiber and coronary heart disease in middle-aged hypercholesterolemic men. Am J Prev Med 1993;9:197-202.
109. Rimm EB, Ascherio A, Giovannucci E, Spiegelman D, Stampfer MJ, Willett WW. Vegetable, fruit, and cereal fiber intake and risk of coronary heart disease among men. JAMA 1996;275:447-51.
110. Lipid Research Clinics Program. The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in the incidence of coronary heart disease. JAMA 1984;251:351-64.